annual CFI:
-$199.19M-$339.80M(-241.67%)Summary
- As of today (July 1, 2025), TARS annual cash flow from investing activities is -$199.19 million, with the most recent change of -$339.80 million (-241.67%) on December 31, 2024.
- During the last 3 years, TARS annual CFI has fallen by -$198.61 million (-33892.32%).
- TARS annual CFI is now -241.67% below its all-time high of $140.60 million, reached on December 31, 2023.
Performance
TARS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$34.94M+$24.63M(+41.35%)Summary
- As of today (July 1, 2025), TARS quarterly cash flow from investing activities is -$34.94 million, with the most recent change of +$24.63 million (+41.35%) on March 31, 2025.
- Over the past year, TARS quarterly CFI has increased by +$67.28 million (+65.82%).
- TARS quarterly CFI is now -154.52% below its all-time high of $64.09 million, reached on June 30, 2023.
Performance
TARS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$131.91M+$67.28M(+33.78%)Summary
- As of today (July 1, 2025), TARS TTM cash flow from investing activities is -$131.91 million, with the most recent change of +$67.28 million (+33.78%) on March 31, 2025.
- Over the past year, TARS TTM CFI has dropped by -$159.00 million (-587.02%).
- TARS TTM CFI is now -193.82% below its all-time high of $140.60 million, reached on December 31, 2023.
Performance
TARS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TARS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -241.7% | +65.8% | -587.0% |
| 3 y3 years | -10000.0% | -10000.0% | -10000.0% |
| 5 y5 years | -10000.0% | -10000.0% | -10000.0% |
TARS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -241.7% | at low | -154.5% | +65.8% | -193.8% | +33.8% |
| 5 y | 5-year | -241.7% | at low | -154.5% | +65.8% | -193.8% | +33.8% |
| alltime | all time | -241.7% | at low | -154.5% | +65.8% | -193.8% | +33.8% |
TARS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$34.94M(-41.3%) | -$131.91M(-33.8%) |
| Dec 2024 | -$199.19M(-241.7%) | -$59.57M(-2004.5%) | -$199.19M(+63.6%) |
| Sep 2024 | - | $3.13M(-107.7%) | -$121.77M(+57.1%) |
| Jun 2024 | - | -$40.52M(-60.4%) | -$77.53M(-386.2%) |
| Mar 2024 | - | -$102.22M(-672.7%) | $27.09M(-80.7%) |
| Dec 2023 | $140.60M(-197.2%) | $17.85M(-62.3%) | $140.60M(+295.7%) |
| Sep 2023 | - | $47.37M(-26.1%) | $35.53M(-151.5%) |
| Jun 2023 | - | $64.09M(+467.5%) | -$68.96M(-48.2%) |
| Mar 2023 | - | $11.29M(-112.9%) | -$133.17M(-7.9%) |
| Dec 2022 | -$144.63M | -$87.22M(+52.7%) | -$144.63M(+150.7%) |
| Sep 2022 | - | -$57.13M(>+9900.0%) | -$57.68M(+8408.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$122.00K(-24.2%) | -$678.00K(+18.5%) |
| Mar 2022 | - | -$161.00K(-41.2%) | -$572.00K(-2.4%) |
| Dec 2021 | -$586.00K(+28.5%) | -$274.00K(+126.4%) | -$586.00K(+123.7%) |
| Sep 2021 | - | -$121.00K(+656.3%) | -$262.00K(-5.1%) |
| Jun 2021 | - | -$16.00K(-90.9%) | -$276.00K(-53.6%) |
| Mar 2021 | - | -$175.00K(-450.0%) | -$595.00K(+30.5%) |
| Dec 2020 | -$456.00K(+160.6%) | $50.00K(-137.0%) | -$456.00K(-9.9%) |
| Sep 2020 | - | -$135.00K(-59.7%) | -$506.00K(+36.4%) |
| Jun 2020 | - | -$335.00K(+830.6%) | -$371.00K(+930.6%) |
| Mar 2020 | - | -$36.00K | -$36.00K |
| Dec 2019 | -$175.00K(+2400.0%) | - | - |
| Dec 2018 | -$7000.00 | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual CFI year-on-year change?
- What is Tarsus Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly CFI year-on-year change?
- What is Tarsus Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM CFI year-on-year change?
What is Tarsus Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of TARS is -$199.19M
What is the all time high annual CFI for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual cash flow from investing activities is $140.60M
What is Tarsus Pharmaceuticals annual CFI year-on-year change?
Over the past year, TARS annual cash flow from investing activities has changed by -$339.80M (-241.67%)
What is Tarsus Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of TARS is -$34.94M
What is the all time high quarterly CFI for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly cash flow from investing activities is $64.09M
What is Tarsus Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, TARS quarterly cash flow from investing activities has changed by +$67.28M (+65.82%)
What is Tarsus Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of TARS is -$131.91M
What is the all time high TTM CFI for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM cash flow from investing activities is $140.60M
What is Tarsus Pharmaceuticals TTM CFI year-on-year change?
Over the past year, TARS TTM cash flow from investing activities has changed by -$159.00M (-587.02%)